Phase 2 Exposure Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
Novartis Pharmaceuticals123 enrolled11 locationsNCT07226986
Recruiting
Phase 1Phase 2
Examining a Novel Gastrointestinal Intervention to Negate Environmental Toxicants (ENGINE)
Toxicant ExposureFirefighterOccupational Exposure to Chemicals
University of California, San Francisco50 enrolled1 locationNCT07226440
Recruiting
Phase 2
Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age
Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis
Dynavax Technologies Corporation148 enrolled3 locationsNCT07207408
Recruiting
Phase 2
Behavioral Exposure for Introceptive Tolerance RCT
AnxietyCardiac RehabilitationExercise Sensitivity+1 more
Rutgers, The State University of New Jersey146 enrolled2 locationsNCT05398276
Recruiting
Phase 2
Can Mineralocorticoid Receptor Antagonism Counteract Cardiometabolic Long-term Effects of Steroids? (MiRACCLES study)
Cardiometabolic complications of excess glucocorticoid exposure
Dr Moe Thuzar60 enrolled1 locationACTRN12622000671763